Insider Trading Alert - CBI, N, LRY, GE And OPK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 19, 2013, 167 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $93.28 to $173,250,000.00.

Highlighted Stocks Traded by Insiders:

Chicago Bridge & Iron Company (CBI) - FREE Research Report

Ballschmiede Ronald A who is Executive Vice President & CFO at Chicago Bridge & Iron Company sold 20,000 shares at $79.25 on Nov. 19, 2013. Following this transaction, the Executive Vice President & CFO owned 162,279 shares meaning that the stake was reduced by 10.97% with the 20,000 share transaction.

The shares most recently traded at $76.25, down $3.00, or 3.94% since the insider transaction. Historical insider transactions for Chicago Bridge & Iron Company go as follows:

  • 4-Week # shares sold: 6,500
  • 12-Week # shares sold: 188,251
  • 24-Week # shares sold: 230,533

The average volume for Chicago Bridge & Iron Company has been 990,200 shares per day over the past 30 days. Chicago Bridge & Iron Company has a market cap of $8.4 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 67.96% year to date as of the close of trading on Tuesday.

Chicago Bridge & Iron Company N.V., an energy infrastructure focused company, provides conceptual design, technology, engineering, procurement, fabrication, construction, and commissioning services to customers in the energy, petrochemical, and natural resource industries worldwide. The stock currently has a dividend yield of 0.26%. The company has a P/E ratio of 23.4. Currently there are 10 analysts that rate Chicago Bridge & Iron Company a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBI - FREE

TheStreet Quant Ratings rates Chicago Bridge & Iron Company as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Chicago Bridge & Iron Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

NetSuite (N) - FREE Research Report

McGeever James who is Chief Operating Officer at NetSuite sold 2,968 shares at $98.41 on Nov. 19, 2013. Following this transaction, the Chief Operating Officer owned 245,103 shares meaning that the stake was reduced by 1.2% with the 2,968 share transaction.

Solomon Douglas P. who is SVP, General Counsel & Sec. at NetSuite sold 1,187 shares at $98.38 on Nov. 19, 2013. Following this transaction, the SVP, General Counsel & Sec. owned 23,949 shares meaning that the stake was reduced by 4.72% with the 1,187 share transaction.

Dilley Timothy who is EVP & Chief Customer Officer at NetSuite sold 931 shares at $98.26 on Nov. 19, 2013. Following this transaction, the EVP & Chief Customer Officer owned 35,407 shares meaning that the stake was reduced by 2.56% with the 931 share transaction.

Goldberg Evan who is CTO & Chairman of the Board at NetSuite sold 21,838 shares at $98.26 on Nov. 19, 2013. Following this transaction, the CTO & Chairman of the Board owned 2.8 million shares meaning that the stake was reduced by 0.77% with the 21,838 share transaction.

Gill Ronald S who is Chief Financial Officer at NetSuite sold 1,514 shares at $98.33 on Nov. 19, 2013. Following this transaction, the Chief Financial Officer owned 43,268 shares meaning that the stake was reduced by 3.38% with the 1,514 share transaction.

The shares most recently traded at $96.00, down $2.33, or 2.43% since the insider transaction. Historical insider transactions for NetSuite go as follows:

  • 4-Week # shares sold: 3,250
  • 12-Week # shares sold: 52,574
  • 24-Week # shares sold: 79,627

The average volume for NetSuite has been 378,200 shares per day over the past 30 days. NetSuite has a market cap of $7.2 billion and is part of the technology sector and computer software & services industry. Shares are up 40.71% year to date as of the close of trading on Tuesday.

NetSuite Inc. provides cloud-based financials/enterprise resource planning (ERP) software suites in the United States and internationally. Currently there are 6 analysts that rate NetSuite a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on N - FREE

TheStreet Quant Ratings rates NetSuite as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full NetSuite Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Liberty Property (LRY) - FREE Research Report

Bowes James J who is Secretary & Gen. Counsel at Liberty Property sold 10,822 shares at $34.66 on Nov. 19, 2013. Following this transaction, the Secretary & Gen. Counsel owned 32,466 shares meaning that the stake was reduced by 25% with the 10,822 share transaction.

The shares most recently traded at $33.87, down $0.79, or 2.33% since the insider transaction. Historical insider transactions for Liberty Property go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 3,000

The average volume for Liberty Property has been 881,800 shares per day over the past 30 days. Liberty Property has a market cap of $5.0 billion and is part of the financial sector and real estate industry. Shares are down 4.08% year to date as of the close of trading on Tuesday.

Liberty Property Trust is a publicly owned real estate investment holding trust. Through its subsidiary, it provides leasing, property management, development, acquisition, and other tenant-related services for a portfolio of industrial and office properties. The stock currently has a dividend yield of 5.53%. The company has a P/E ratio of 33.3. Currently there is 1 analyst that rates Liberty Property a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LRY - FREE

TheStreet Quant Ratings rates Liberty Property as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, expanding profit margins, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Liberty Property Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

General Electric (GE) - FREE Research Report

Comstock Elizabeth J who is Senior Vice President at General Electric sold 60,000 shares at $27.27 on Nov. 19, 2013. Following this transaction, the Senior Vice President owned 39,918 shares meaning that the stake was reduced by 60.05% with the 60,000 share transaction.

The shares most recently traded at $27.05, down $0.22, or 0.81% since the insider transaction.

The average volume for General Electric has been 38.2 million shares per day over the past 30 days. General Electric has a market cap of $275.4 billion and is part of the industrial goods sector and industrial industry. Shares are up 29.68% year to date as of the close of trading on Tuesday.

General Electric Company operates as an infrastructure and financial services company worldwide. The stock currently has a dividend yield of 2.79%. The company has a P/E ratio of 19.6. Currently there are 7 analysts that rate General Electric a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GE - FREE

TheStreet Quant Ratings rates General Electric as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full General Electric Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 24,800 shares at $9.93 on Nov. 19, 2013. Following this transaction, the CEO & Chairman owned 137.1 million shares meaning that the stake was reduced by 0.02% with the 24,800 share transaction.

The shares most recently traded at $10.11, up $0.18, or 1.77% since the insider transaction.

The average volume for Opko Health has been 4.9 million shares per day over the past 30 days. Opko Health has a market cap of $3.9 billion and is part of the health care sector and health services industry. Shares are up 98.54% year to date as of the close of trading on Tuesday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and deteriorating net income. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Jim Cramer: Aramark Is a Great Company but It's Levered to Baseball

Jim Cramer: Aramark Is a Great Company but It's Levered to Baseball

Preferred Stock & Common Stock: What's the Difference?

Preferred Stock & Common Stock: What's the Difference?

It's Not Over Yet: Keep an Eye on FANG Stocks

It's Not Over Yet: Keep an Eye on FANG Stocks

5 Stocks That Are Screaming Buys Right Now

5 Stocks That Are Screaming Buys Right Now

Jim Cramer on the Markets: 2:45pm Is a Make or Break Level

Jim Cramer on the Markets: 2:45pm Is a Make or Break Level